EW GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
EW
CompareEdwards Lifesciences Corp
Exchange: NYSESector: HealthcareIndustry: Medical Devices
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Did you know?
A large-cap company with a $47.3B market cap.
Current Price
$81.53
+2.28%GoodMoat Value
$55.68
31.7% overvaluedProfile
Valuation (TTM)
Market Cap$47.29B
P/E44.05
EV$44.05B
P/B4.57
Shares Out580.00M
P/Sales7.79
Revenue$6.07B
EV/EBITDA29.31
Edwards Lifesciences Corp (EW) Quality Analysis
EW Profitability
Profitability trend analysis coming soon
EW Growth
Growth trend analysis coming soon
EW Financial Health
Financial health indicators coming soon
EW Quality & Fundamental Analysis
Edwards Lifesciences Corp (EW) is a Healthcare company in the Medical Devices industry, listed on NYSE. This quality analysis page evaluates Edwards Lifesciences Corp's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Edwards Lifesciences Corp has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 17.69% and a return on equity (ROE) of 10.38%. Return on assets (ROA) stands at 7.84%.
The debt-to-equity ratio is 0.07, with a current ratio of 3.72. Operating margin is 18.21%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Edwards Lifesciences Corp is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.